Abcam, Inc. Sustainability Profile
Abcam, Inc., a leading life sciences company headquartered in the United States, has established itself as a prominent player in the biotechnology industry since its founding in 1998. With a strong focus on providing high-quality research tools, Abcam is renowned for its extensive range of antibodies, proteins, and assays, catering to the needs of researchers in academia and industry alike. Operating globally, Abcam has major facilities in the US, Europe, and Asia, ensuring a robust supply chain and customer support network. The company’s commitment to innovation and quality has positioned it as a trusted partner in scientific research, with notable achievements including a vast catalogue of over one million products. Abcam’s unique offerings, such as recombinant antibodies and advanced imaging solutions, set it apart in a competitive market, making it an essential resource for advancing biological research.
DitchCarbon Score
How does Abcam, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abcam, Inc.'s score of 48 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abcam, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Danaher Corporation, which influences its climate commitments and emissions reporting. As part of its corporate family, Abcam inherits climate initiatives and targets from Danaher Corporation, including those related to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). While specific reduction targets or achievements for Abcam, Inc. are not detailed, the overarching commitments from Danaher Corporation suggest a focus on sustainability and emissions reduction. Abcam Limited, a related entity, may also contribute to the overall performance metrics, although specific figures are not disclosed. In summary, while Abcam, Inc. does not present its own emissions data or reduction targets, it is aligned with the climate strategies of its parent company, Danaher Corporation, indicating a commitment to addressing climate change within its operational framework.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 1,554,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,198,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 4,752,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Abcam, Inc.'s Industry?
How Carbon Intensive is Abcam, Inc.'s Location?
Abcam, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abcam, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Quest Diagnostics
Pharmaceutical Product Development, LLC
Syneos Health
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.